Extrapyramidal symptoms
Drug-induced movement disorders
Extrapyramidal symptoms (EPS) are symptoms that are archetypically associated with the extrapyramidal system of the brain. When such symptoms are caused by medications or other drugs, they are also known as extrapyramidal side effects (EPSE). The symptoms can be acute (short-term) or chronic (long-term).
Nº Q1385411 ★★★
Rare · Knowledge
Extrapyramidal symptoms
Drug-induced movement disorders
Extrapyramidal symptoms (EPS) are symptoms that are archetypically associated with the extrapyramidal system of the brain. When such symptoms are caused by medications or other drugs, they are also known as extrapyramidal side effects (EPSE). The symptoms can be acute (short-term) or chronic (long-term).
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Extrapyramidal symptoms (EPS) are symptoms that are archetypically associated with the extrapyramidal system of the brain. When such symptoms are caused by medications or other drugs, they are also known as extrapyramidal side effects (EPSE). The symptoms can be acute (short-term) or chronic (long-term). They include movement dysfunction such as dystonia (continuous spasms and muscle contractions), akathisia (may manifest as motor restlessness), parkinsonism characteristic symptoms such as rigidity, bradykinesia (slowness of movement), tremor, and tardive dyskinesia (irregular, jerky movements). Extrapyramidal symptoms are a reason why subjects drop out of clinical trials of antipsychotics; of the 213 (14.6%) subjects that dropped out of one of the largest clinical trials of antipsychotics (the CATIE trial [Clinical Antipsychotic Trials for Intervention Effectiveness], which included 1460 randomized subjects), 58 (27.2%) of those discontinuations were due to EPS.
Text: Wikipédia, CC BY-SA 4.0. ·
Related cards
neuroleptic extrapyramidal disorder
Extrapyramidal side-effects of neuroleptic (antipsychotic) drugs
Nº Q32820424 ★★★★
Parkinson's disease
Long-term degenerative neurological disorder
Nº Q11085 ★★★★★
Post-exertional malaise
Symptom of chronic fatigue syndrome
Nº Q42417507 ★★★
Essential tremor
Movement disorder causing involuntary tremors, especially in the hand
Nº Q693519 ★★★
Excessive daytime sleepiness
Symptom characterized by persistent sleepiness during daytime
Nº Q3144201 ★★
Narcolepsy
Human sleep disorder that involves an excessive urge to sleep and other neurological features
Nº Q189561 ★★★★